Log In
Print
BCIQ
Print
Print this Print this
 

Dermagraft (ABH001)

  Manage Alerts
Collapse Summary General Information
Company Organogenesis Inc.
DescriptionEngineered skin substitute containing live human fibroblasts grown on an absorbable Vicryl mesh
Molecular Target Not available
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Organ/tissue engineering
Latest Stage of DevelopmentMarketed
Standard IndicationDermal ulcers
Indication DetailsPressure ulcers and skin ulcers (diabetic and venous); Treat chronic foot ulcers; Treat diabetic foot ulcers; Treat venous leg ulcers
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today